• Praveen Eadala


Jaundice is not a diagnosis but a manifestation of pathology.


Primary Biliary Cirrhosis Portal Vein Thrombosis Acute Liver Failure Biliary Tract Cancer Wilson Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Trauner M, Fickert P, Zollner G. Genetic disorders and molecular mechanisms in cholestatic liver disease – a clinical approach. Semin Gastrointest Dis. 2001;12(2):66–88.PubMedGoogle Scholar
  2. 2.
    London IM, West R, Shemin D, Rittenberg D. On the origin of bile pigment in normal man. J Biol Chem. 1950;184(1):351–8.PubMedGoogle Scholar
  3. 3.
    Berk PD, Wolkoff AW, Berlin NI. Inborn errors of bilirubin metabolism. Med Clin North Am. 1975;59(4):803–16.CrossRefPubMedGoogle Scholar
  4. 4.
    Schmid R. Bilirubin metabolism in man. N Engl J Med. 1972;287(14):703–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Lee WM. Acute liver failure. Am J Med. 1994;96(1A):3S–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137(12):947–54.CrossRefPubMedGoogle Scholar
  7. 7.
    Pasanen PA, Pikkarainen P, Alhava E, Partanen K, Janatuinen E. Evaluation of a computer-based diagnostic score system in the diagnosis of jaundice and cholestasis. Scand J Gastroenterol. 1993;28(8):732–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Lalani T, Couto CA, Rosen MP, Baker ME, Blake MA, Cash BD, et al. ACR appropriateness criteria jaundice. J Am Coll Radiol. 2013;10(6):402–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Pasanen PA, Partanen KP, Pikkarainen PH, Alhava EM, Janatuinen EK, Pirinen AE. A comparison of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the differential diagnosis of benign and malignant jaundice and cholestasis. Eur J Surg. 1993;159(1):23–9.PubMedGoogle Scholar
  10. 10.
    Adler DG, Baron TH, Davila RE, Egan J, Hirota WK, Leighton JA, et al. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc. 2005;62(1):1–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Baron TH. Endoscopy for bile duct stones. Minerva Gastroenterol Dietol. 2005;51(4):289–301.PubMedGoogle Scholar
  12. 12.
    Baron TH. Palliation of malignant obstructive jaundice. Gastroenterol Clin North Am. 2006;35(1):101–12.CrossRefPubMedGoogle Scholar
  13. 13.
    Poynard T, Benhamou Y, Thabut D, Ratziu V. Liver biopsy: the best standard…when everything else fails. J Hepatol. 2009;50(6):1267–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology. 2009;49(3):1017–44.CrossRefPubMedGoogle Scholar
  15. 15.
    McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology. 1990;99(5):1396–400.PubMedGoogle Scholar
  16. 16.
    Wada K, Takada T, Kawarada Y, Nimura Y, Miura F, Yoshida M, et al. Diagnostic criteria and severity assessment of acute cholangitis: Tokyo guidelines. J Hepatobiliary Pancreat Surg. 2007;14(1):52–8.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med. 1999;341(18):1368–78.CrossRefPubMedGoogle Scholar
  18. 18.
    Wolf SJ, Heard K, Sloan EP, Jagoda AS. Clinical policy: critical issues in the management of patients presenting to the emergency department with acetaminophen overdose. Ann Emerg Med. 2007;50(3):292–313.CrossRefPubMedGoogle Scholar
  19. 19.
    Ferner RE, Dear JW, Bateman DN. Management of paracetamol poisoning. BMJ. 2011;342:d2218.CrossRefPubMedGoogle Scholar
  20. 20.
    Pettie JM, Dow MA, Sandilands EA, Thanacoody HK, Bateman DN. An integrated care pathway improves the management of paracetamol poisoning. Emerg Med J. 2012;29(6):482–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988;319(24):1557–62.CrossRefPubMedGoogle Scholar
  22. 22.
    Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics. 1975;55(6):871–6.PubMedGoogle Scholar
  23. 23.
    Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51(6):2193–213.CrossRefPubMedGoogle Scholar
  24. 24.
    Krawitt EL. Clinical features and management of autoimmune hepatitis. World J Gastroenterol. 2008;14(21):3301–5.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Gleeson D, Heneghan MA. British society of gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut. 2011;60(12):1611–29.CrossRefPubMedGoogle Scholar
  26. 26.
    Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an update on the 2007 overview. Expert Opin Drug Saf. 2007;13(1):67–81.CrossRefGoogle Scholar
  27. 27.
    Leise MD, Poterucha JJ, Talwalkar JA. Drug-induced liver injury. Mayo Clin Proc. 2014;89(1):95–106.CrossRefPubMedGoogle Scholar
  28. 28.
    Larrey D, Rueff B, Feldmann G, Degott C, Danan G, Benhamou JP. Recurrent jaundice caused by recurrent hyperemesis gravidarum. Gut. 1984;25(12):1414–5.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Fisk NM, Bye WB, Storey GN. Maternal features of obstetric cholestasis: 20 years experience at King George V Hospital. Aust N Z J Obstet Gynaecol. 1988;28(3):172–6.CrossRefPubMedGoogle Scholar
  30. 30.
    Fisk NM, Storey GN. Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol. 1988;95(11):1137–43.CrossRefPubMedGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Department of GastroenterologyABM University Health Board, Morriston HospitalSwanseaUK

Personalised recommendations